Methods and compositions for treating melanoma
US-2024424002-A1 · Dec 26, 2024 · US
US8945829B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8945829-B2 |
| Application number | US-201314032785-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 20, 2013 |
| Priority date | Mar 22, 2011 |
| Publication date | Feb 3, 2015 |
| Grant date | Feb 3, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The application describes methods for accurately evaluating whether thyroid test samples, especially indeterminate thyroid samples, are benign or malignant.
Opening claim text (preview).
What is claimed is: 1. A method of identifying a test thyroid tissue sample as a malignant thyroid tissue sample or a benign thyroid tissue sample, the method comprising: i. determining a quantified expression level of mir-328, mir-222, mir-197, and mir-21 RNA in the test thyroid tissue sample to produce a test dataset of expression levels; ii. comparing the test dataset of expression levels consisting of mir-328, mir-222, mir-197, and mir-21 to a malignant thyroid dataset and t…
Physics · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.